Skip to content

Clinical trials

Phase 1/2 Brain Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 1/2 Country / region: United States Clear all

134 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20015
20027
20034
20044
20055
20065
20073
20082
20094
201010
20115
20126
20135
20144
20153
20168
20175
20185
20191
20204
20213
20224
20237
20244
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Terminated23
Recruiting20
Active, not recruiting11
Unknown status6
Withdrawn4
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)18
M.D. Anderson Cancer Center9
New Approaches to Brain Tumor Therapy Consortium7
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins6
Novartis Pharmaceuticals5
Northwell Health4
Duke University3
Stanford University3
Case Comprehensive Cancer Center2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms134
Glioblastoma78
Glioma46
Gliosarcoma45
Central Nervous System Neoplasms40
Astrocytoma36
Oligodendroglioma28
Neoplasms13
Breast Neoplasms12
Melanoma12

Trials

Showing 1 to 25 of 134. Each trial links to its page on Pharma Observatory.

34 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.